Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have not received any cancer treatment (such as systemic therapies or radiation therapy) in the past month, except for surgery or introductory chemotherapy.
- People who are scheduled to receive 15 or more treatment sessions (fractions) of radiation.
- People who are male or female and are older than 18 years of age at the time of signing the consent form.
- People who are able to understand a written consent document.
- People who are willing and able to complete all study questionnaires and provide blood and stool samples before, during, and after treatment.
- People who are willing to have their medical records reviewed for clinical information.
- People who are able to read, write, and understand English or Spanish.
Who may not be able to join:
- People for whom having blood drawn is medically inadvisable — specifically, those for whom providing approximately 50 mL of blood over a 6-week period would pose a health risk.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sue Yom, MD, University of California, San Francisco
Phone: (415) 530-9805
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measure associations between changes in cancer-related fatigue (CRF) and changes in gene expression over time; Measure associations between changes in CRF and changes in cytokine levels over time; Measure associations between changes in CRF and changes in gene expression over time; Evaluate the predictive utility of gene expression and cytokine data
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.